Pet obesity is rising rapidly, and veterinarians are running out of tools to combat it. Now, a first-of-its-kind clinical study suggests that weight loss drugs, previously only used in humans, may soon also benefit our four-legged friends. The idea sounds wild at first, but the science behind it is gaining momentum. For many families, this could mean a safer and more structured way to help an overweight cat live longer and feel better.
Pet owners know the struggle. You cut back on food, try new diets, and toss toys to spark more play, yet the scale barely moves. When almost 60 percent of cats in the U.S. are overweight, the usual advice falls short. A new treatment currently under testing could offer an alternative path.
A First-of-Its-Kind Test for Cats
A San Francisco company, Okava Pharmaceuticals, has launched a milestone trial called MEOW-1. It is the first clinical weight loss study built for everyday pets rather than research animals. Fifty cats are taking part. Each recipient receives a tiny implant, the OKV-119, which sits under the skin and slowly releases a GLP-1-based drug over a six-month period.
The goal is to copy the natural effects of fasting without changing a cat's routine. The treatment aims to improve insulin sensitivity and reduce fat mass while maintaining a steady feeding schedule. That matters because food is often part of the bond between pets and their people. Okava expects early data in 2026. If things go well, the company hopes to pursue FDA approval for cats within the next few years.
Hiang / Pexels / Researchers say this could shift veterinary care. Instead of constant diet battles at home, vets could have a medical tool to support steady, controlled weight loss.
It would not replace healthy habits, but it could help cats who simply do not respond to traditional plans.
Why This Means for Cats
Obesity takes years off a cat's life. Vets see the same pattern over and over. Extra weight raises the risk of diabetes, strains the joints, and slows the heart. Once these problems begin, treatment gets expensive and complicated. The simplest path to a longer life is a leaner body.
Dr. Ernie Ward, a leading voice on pet obesity, says the old advice to feed less and play more does not work for many cats. Biology gets in the way. Some cats store fat more easily. Others feel hungry even on reduced diets and become stressed or anxious. Medically guided weight loss could make the process safer and more humane.
However, the benefits go beyond looks. A cat that drops extra pounds often moves with more ease, jumps again, and shows brighter energy. Owners sometimes notice a shift in attitude. The change can feel small at first, but it can build into a stronger quality of life.
How the Implant Works and What Comes Next?
David / Unsplash / The drug inside the implant comes from the same family as Ozempic and Wegovy. These drugs slow down how fast food leaves the stomach, which helps pets feel full longer.
Okava chose exenatide, an older GLP-1 drug already approved for human use. Using a generic version keeps the cost down and avoids the high prices tied to newer medications.
As the implant releases the drug, a cat may feel less drawn to food. Owners might notice less begging or scavenging. The process is slow and steady by design, so the body can adjust. Okava aims to keep the price about one hundred dollars per month once approved. A version for dogs is already in development, which suggests this field is about to grow.
Vet teams will likely handle the implants as part of supervised weight care programs. This will help track side effects and adjust plans if needed. Long-term safety and results are still unknown, which is why this early research matters so much.
Remember, MEOW-1 is not the only project in the works. Several companies are racing to create pet-friendly GLP-1 options, including medicated treats. Until now, the biggest challenge has been cost.